Literature DB >> 1556638

The nervous systems of helminths as targets for drugs.

T G Geary1, R D Klein, L Vanover, J W Bowman, D P Thompson.   

Abstract

Processes that critically differentiate parasitic helminths and their hosts are obvious candidates for chemotherapeutic intervention. The recognition that neurobiology distinguishes helminths from their vertebrate hosts is due in part to the fact that several efficacious anthelmintics, derived generally from empirical screening, have been found to act selectively on the neuromuscular system of these parasites. In addition, basic physiological and pharmacological research has revealed considerable differences in the ways in which helminths and their hosts transmit information in the nervous system and respond to it in innervated tissues. Unfortunately, most of these differences have yet to be exploited in chemotherapy. The topics for this review include an analysis of mechanistic aspects of the pharmacology of anthelmintics that act on neuromuscular systems and a consideration of the prospects for discovery of novel drugs that act on this system.

Mesh:

Substances:

Year:  1992        PMID: 1556638

Source DB:  PubMed          Journal:  J Parasitol        ISSN: 0022-3395            Impact factor:   1.276


  10 in total

1.  avr-15 encodes a chloride channel subunit that mediates inhibitory glutamatergic neurotransmission and ivermectin sensitivity in Caenorhabditis elegans.

Authors:  J A Dent; M W Davis; L Avery
Journal:  EMBO J       Date:  1997-10-01       Impact factor: 11.598

2.  High-performance liquid chromatographic analysis of monoamines in the cestode Diphyllobothrium dendriticum.

Authors:  K Eriksson; M Gustafsson; G Akerlind
Journal:  Parasitol Res       Date:  1993       Impact factor: 2.289

3.  Pharmacological evaluation of contractile activity of the dog heartworm Dirofilaria immitis.

Authors:  J M Bowen; B Vitayavirasak
Journal:  Vet Res Commun       Date:  2007-09-25       Impact factor: 2.459

Review 4.  Parasite neuropeptide biology: Seeding rational drug target selection?

Authors:  Paul McVeigh; Louise Atkinson; Nikki J Marks; Angela Mousley; Johnathan J Dalzell; Ann Sluder; Lance Hammerland; Aaron G Maule
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2011-11-15       Impact factor: 4.077

5.  Paralytic effect of alcoholic extract of Allium sativum and Piper longum on liver amphistome, Gigantocotyle explanatum.

Authors:  T U Singh; D Kumar; S K Tandan
Journal:  Indian J Pharmacol       Date:  2008-03       Impact factor: 1.200

Review 6.  Family of FLP Peptides in Caenorhabditis elegans and Related Nematodes.

Authors:  Chris Li; Kyuhyung Kim
Journal:  Front Endocrinol (Lausanne)       Date:  2014-10-14       Impact factor: 5.555

7.  Coalescing beneficial host and deleterious antiparasitic actions as an antischistosomal strategy.

Authors:  John D Chan; Timothy A Day; Jonathan S Marchant
Journal:  Elife       Date:  2018-07-30       Impact factor: 8.140

Review 8.  The interplay of helminthic neuropeptides and proteases in parasite survival and host immunomodulation.

Authors:  Rimanpreet Kaur; Naina Arora; Meera G Nair; Amit Prasad
Journal:  Biochem Soc Trans       Date:  2022-02-28       Impact factor: 4.919

9.  Egg-laying and locomotory screens with C. elegans yield a nematode-selective small molecule stimulator of neurotransmitter release.

Authors:  Sean Harrington; Jessica J Knox; Andrew R Burns; Ken-Loon Choo; Aaron Au; Megan Kitner; Cecile Haeberli; Jacob Pyche; Cassandra D'Amata; Yong-Hyun Kim; Jonathan R Volpatti; Maximillano Guiliani; Jamie Snider; Victoria Wong; Bruna M Palmeira; Elizabeth M Redman; Aditya S Vaidya; John S Gilleard; Igor Stagljar; Sean R Cutler; Daniel Kulke; James J Dowling; Christopher M Yip; Jennifer Keiser; Inga Zasada; Mark Lautens; Peter J Roy
Journal:  Commun Biol       Date:  2022-08-24

10.  Structure-activity profiling of alkaloid natural product pharmacophores against a Schistosoma serotonin receptor.

Authors:  Jonathan S Marchant; Wayne W Harding; John D Chan
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2018-09-28       Impact factor: 4.077

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.